Asensus Surgical (ASXC) Stock Price, News & Analysis

0.00 (0.00%)
(As of 05/17/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.52 million shs
Average Volume
972,558 shs
Market Capitalization
$70.81 million
P/E Ratio
Dividend Yield
Price Target

Asensus Surgical MarketRank™ Stock Analysis

Analyst Rating
2.00 Rating Score
159.6% Upside
$0.68 Price Target
Short Interest
6.04% of Float Sold Short
Dividend Strength
News Sentiment
-0.38mentions of Asensus Surgical in the last 14 days
Based on 16 Articles This Week
Insider Trading
Proj. Earnings Growth
From ($0.19) to ($0.13) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.54 out of 5 stars

ASXC stock logo

About Asensus Surgical Stock (NYSEAMERICAN:ASXC)

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.

ASXC Stock Price History

ASXC Stock News Headlines

Asensus Surgical earnings: here's what Wall Street expects
Asensus Surgical Agrees To Karl Storz's Acquisition Offer; Stock Up
ASXC Oct 2024 0.500 put
Asensus Surgical Earnings Preview
Recap: Asensus Surgical Q4 Earnings
See More Headlines
Receive ASXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Asensus Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
2 Analysts


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
$8.58 million
Book Value
$0.05 per share


Free Float
Market Cap
$70.81 million
Not Optionable
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Mr. Anthony  FernandoMr. Anthony Fernando (Age 52)
    President, CEO & Director
    Comp: $901.03k
  • Mr. Shameze Rampertab B.Sc. MBA (Age 57)
    CA, CPA, Executive VP & CFO
    Comp: $511.25k
  • Mr. Joshua B. Weingard (Age 51)
    Chief Legal Officer & Secretary
  • Mr. Paul Ziegler Jr. (Age 50)
    J.D., Vice President of Sales
  • Mr. Ethan Loiselle
    Vice President of Global Marketing
  • Ms. Amanda Owens
    Vice President of People
  • Mr. Ravi Kommineni
    Head of Global Quality & Regulatory
  • Mr. Motti Frimer
    Vice President of R&D, Digital Solutions and MD of Asensus Surgical

ASXC Stock Analysis - Frequently Asked Questions

Should I buy or sell Asensus Surgical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Asensus Surgical in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ASXC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ASXC, but not buy additional shares or sell existing shares.
View ASXC analyst ratings
or view top-rated stocks.

What is Asensus Surgical's stock price target for 2024?

2 brokerages have issued twelve-month target prices for Asensus Surgical's stock. Their ASXC share price targets range from $0.35 to $1.00. On average, they expect the company's stock price to reach $0.68 in the next twelve months. This suggests a possible upside of 159.6% from the stock's current price.
View analysts price targets for ASXC
or view top-rated stocks among Wall Street analysts.

Are investors shorting Asensus Surgical?

Asensus Surgical saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 16,510,000 shares, a decrease of 7.0% from the March 31st total of 17,750,000 shares. Based on an average daily volume of 1,580,000 shares, the short-interest ratio is presently 10.4 days. Currently, 6.2% of the shares of the company are short sold.
View Asensus Surgical's Short Interest

How were Asensus Surgical's earnings last quarter?

Asensus Surgical, Inc. (NYSEAMERICAN:ASXC) released its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.07) earnings per share for the quarter, missing the consensus estimate of ($0.05) by $0.02. The firm earned $1.12 million during the quarter, compared to the consensus estimate of $1.10 million. Asensus Surgical had a negative trailing twelve-month return on equity of 184.10% and a negative net margin of 902.25%.

Who are Asensus Surgical's major shareholders?

Asensus Surgical's stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Andrea Biffi, Anthony C J Fernando, David Bruce Milne, Elizabeth Kwo and William N Starling Jr.
View institutional ownership trends

How do I buy shares of Asensus Surgical?

Shares of ASXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:ASXC) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners